Bank Pictet & Cie Asia LTD Boosted Position in Johnson & Johnson (JNJ) by $956,616 as Share Value Rose; Dollar General (DG) Shareholder Professional Advisory Services Has Cut Its Position by $1.23 Million as Stock Value Declined

Johnson & Johnson (NYSE:JNJ) Logo

Bank Pictet & Cie Asia Ltd increased its stake in Johnson & Johnson (JNJ) by 7.97% based on its latest 2018Q3 regulatory filing with the SEC. Bank Pictet & Cie Asia Ltd bought 6,932 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 93,932 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $12.98 million, up from 87,000 at the end of the previous reported quarter. Bank Pictet & Cie Asia Ltd who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $347.88B market cap company. The stock increased 0.60% or $0.78 during the last trading session, reaching $129.71. About 6.22 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since January 11, 2018 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 17/04/2018 – Johnson & Johnson 1Q EPS $1.60; 30/04/2018 – Football Rumors: Steelers Release S J.J. Wilcox; 27/03/2018 – FDA: Johnson & Johnson Vision Care, Inc.- ACUVUE OASYS Brand Contact Lenses with HYDRACLEAR PLUS; 24/05/2018 – Is Hank Fuchs tearing up about JJ?; 29/05/2018 – #3 Genmab takes a hit after J&J sounds retreat on cancer combos, as patient deaths force researches to scrap trials; 26/04/2018 – FUJIREBIO SAYS ENTERED INTO AGREEMENT WITH JANSSEN PHARMACEUTICALS TO DEVELOP & COMMERCIALIZE AMYLOID; 08/05/2018 – J&J’s Janssen: FDA Approval Marks the Fifth Indication for Darzalex, Which Is the First CD38-Directed Antibody to Be Approved Anywhere; 16/04/2018 – THE JANSSEN PHARMACEUTICAL COMPANIES – ENTERED WORLDWIDE COLLABORATION WITH BRISTOL-MYERS TO DEVELOP, COMMERCIALIZE FACTOR XIA INHIBITORS; 06/03/2018 – Johnson & Johnson to Participate in Barclays Global Healthcare Conference; 16/04/2018 – JANSSEN – UNDER AGREEMENT, CO, BRISTOL-MYERS SQUIBB TO ADVANCE BMS-986177 INTO PHASE 2 CLINICAL TRIALS

Professional Advisory Services Inc decreased its stake in Dollar General (DG) by 7.61% based on its latest 2018Q3 regulatory filing with the SEC. Professional Advisory Services Inc sold 11,247 shares as the company’s stock declined 5.21% with the market. The institutional investor held 136,603 shares of the department and specialty retail stores company at the end of 2018Q3, valued at $14.93 million, down from 147,850 at the end of the previous reported quarter. Professional Advisory Services Inc who had been investing in Dollar General for a number of months, seems to be less bullish one the $30.63 billion market cap company. The stock increased 0.88% or $1.02 during the last trading session, reaching $116.52. About 2.18M shares traded. Dollar General Corporation (NYSE:DG) has risen 13.14% since January 11, 2018 and is uptrending. It has outperformed by 13.14% the S&P500. Some Historical DG News: 15/03/2018 – RPT-DOLLAR GENERAL CORP – SHARE REPURCHASES FOR FISCAL YEAR 2018 ARE EXPECTED TO BE APPROXIMATELY $850 MLN; 26/03/2018 – Moody’s Rates Dollar General’s New Notes Baa2; 15/03/2018 – Dollar General Increases Shr Repurchase Program Authorization by $1B; 15/03/2018 – RPT-DOLLAR GENERAL CORP DG.N SEES FY 2018 SHR $5.95 TO $6.15; 15/03/2018 – Dollar General 4Q Net $712.2M; 08/03/2018 – Dollar General To Give Up To 8 Weeks Parental Leave And Adoption Assistance Benefit — MarketWatch; 08/03/2018 – DOLLAR GENERAL CORP – ALL OTHER PARENTS TO RECEIVE TWO WEEKS OF PAID PARENTAL LEAVE; 15/03/2018 – DOLLAR GENERAL BOOSTS QTR DIV TO 29C/SHR FROM 26C, EST. 27C; 16/05/2018 – Dollar General Closes Above 50-Day Moving Average: Technicals; 15/03/2018 – Dollar General FY18 Capital Expenditures Expected to Be $725M-$800M

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $136.03’s average target is 4.87% above currents $129.71 stock price. Johnson & Johnson had 110 analyst reports since August 7, 2015 according to SRatingsIntel. Wells Fargo upgraded Johnson & Johnson (NYSE:JNJ) rating on Monday, October 9. Wells Fargo has “Buy” rating and $149.0 target. As per Wednesday, October 18, the company rating was maintained by Argus Research. Atlantic Securities initiated it with “Neutral” rating and $95 target in Friday, December 18 report. BTIG Research downgraded the stock to “Sell” rating in Friday, July 21 report. Jefferies maintained the shares of JNJ in report on Friday, July 14 with “Hold” rating. Jefferies maintained the shares of JNJ in report on Friday, June 16 with “Hold” rating. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Tuesday, July 18 by BMO Capital Markets. On Monday, March 14 the stock rating was upgraded by Goldman Sachs to “Neutral”. Credit Suisse maintained the shares of JNJ in report on Friday, April 20 with “Outperform” rating. The rating was downgraded by Alembic on Friday, July 21 to “Underweight”.

Since August 27, 2018, it had 3 insider buys, and 8 sales for $79.44 million activity. On Friday, December 14 PRINCE CHARLES bought $268,731 worth of Johnson & Johnson (NYSE:JNJ) or 2,000 shares. Duato Joaquin had sold 40,000 shares worth $5.77 million. 1,000 shares were bought by PEREZ WILLIAM D, worth $133,910. 3,643 shares valued at $536,638 were sold by Kapusta Ronald A on Thursday, December 13. $38.60 million worth of Johnson & Johnson (NYSE:JNJ) shares were sold by Gorsky Alex. $100,050 worth of stock was bought by MULCAHY ANNE M on Friday, December 14.

Bank Pictet & Cie Asia Ltd, which manages about $216.98M US Long portfolio, decreased its stake in Alibaba Group Hldg Ltd (NYSE:BABA) by 4,680 shares to 17,560 shares, valued at $2.89M in 2018Q3, according to the filing. It also reduced its holding in Tjx Cos Inc New (NYSE:TJX) by 4,113 shares in the quarter, leaving it with 8,272 shares, and cut its stake in Hca Healthcare Inc (NYSE:HCA).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Finance.Yahoo.com which released: “The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial – Yahoo! Finance News” on December 21, 2018, also Seekingalpha.com with their article: “Latest trial over J&J’s talc-based products – Seeking Alpha” published on January 08, 2019, Seekingalpha.com published: “Lawsuit Protection For Johnson & Johnson – Seeking Alpha” on December 17, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson boosts prices on top-selling drugs – Seeking Alpha” published on January 10, 2019 as well as Investorplace.com‘s news article titled: “5 Healthcare Stocks That Are Feeling Sick – Investorplace.com” with publication date: December 18, 2018.

Investors sentiment increased to 1.05 in Q3 2018. Its up 0.08, from 0.97 in 2018Q2. It is positive, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Acg Wealth reported 53,208 shares. Pinnacle Wealth Mgmt Advisory Group holds 30,788 shares. Ing Groep Nv accumulated 596,330 shares. Private Wealth Advsrs invested 1.76% in Johnson & Johnson (NYSE:JNJ). Premier Asset Mngmt Lc invested in 0.09% or 2,911 shares. 115,510 were reported by Petrus Tru Company Lta. Td Cap Management Limited has 0.01% invested in Johnson & Johnson (NYSE:JNJ) for 150 shares. Fiduciary Financial Ser Of The Southwest Tx holds 0.61% in Johnson & Johnson (NYSE:JNJ) or 15,875 shares. Riggs Asset Managment Inc has 3,801 shares. Hallmark Capital Mngmt Inc holds 2.41% or 147,785 shares. Creative Planning reported 460,048 shares or 0.24% of all its holdings. Boys Arnold & has invested 1.56% in Johnson & Johnson (NYSE:JNJ). Ronna Sue Cohen holds 3.26% or 34,843 shares. Optimum Inv Advisors has invested 0.5% in Johnson & Johnson (NYSE:JNJ). Ht Prtnrs Ltd Llc holds 12,999 shares.

Analysts await Dollar General Corporation (NYSE:DG) to report earnings on March, 21. They expect $1.87 earnings per share, up 26.35% or $0.39 from last year’s $1.48 per share. DG’s profit will be $491.59 million for 15.58 P/E if the $1.87 EPS becomes a reality. After $1.26 actual earnings per share reported by Dollar General Corporation for the previous quarter, Wall Street now forecasts 48.41% EPS growth.

Among 32 analysts covering Dollar General Corp. (NYSE:DG), 22 have Buy rating, 1 Sell and 9 Hold. Therefore 69% are positive. Dollar General Corp. has $125 highest and $6200 lowest target. $102.33’s average target is -12.18% below currents $116.52 stock price. Dollar General Corp. had 129 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Underperform” rating by Credit Suisse given on Thursday, March 23. The firm has “Market Perform” rating given on Friday, December 8 by Telsey Advisory Group. The stock of Dollar General Corporation (NYSE:DG) has “Outperform” rating given on Monday, February 6 by Bernstein. The stock has “Outperform” rating by RBC Capital Markets on Friday, May 27. The stock of Dollar General Corporation (NYSE:DG) has “Buy” rating given on Monday, December 4 by UBS. The stock has “Buy” rating by Citigroup on Wednesday, September 13. The company was maintained on Monday, April 4 by Macquarie Research. As per Friday, August 26, the company rating was downgraded by JP Morgan. The company was downgraded on Wednesday, September 7 by Wolfe Research. The firm has “Sector Weight” rating by KeyBanc Capital Markets given on Thursday, October 13.

Investors sentiment decreased to 1.14 in 2018 Q3. Its down 0.12, from 1.26 in 2018Q2. It is negative, as 36 investors sold DG shares while 214 reduced holdings. 95 funds opened positions while 191 raised stakes. 235.66 million shares or 1.17% less from 238.45 million shares in 2018Q2 were reported. Barclays Public Limited has 0.04% invested in Dollar General Corporation (NYSE:DG). Ims Mngmt owns 50 shares. Tt International owns 85,409 shares for 1.04% of their portfolio. Renaissance Limited Com has 0.12% invested in Dollar General Corporation (NYSE:DG) for 1.08 million shares. 574,177 were accumulated by Teacher Retirement Systems Of Texas. Oregon Public Employees Retirement Fund stated it has 0.14% of its portfolio in Dollar General Corporation (NYSE:DG). Moreover, Conning has 0.02% invested in Dollar General Corporation (NYSE:DG) for 5,370 shares. Bokf Na invested 0.09% of its portfolio in Dollar General Corporation (NYSE:DG). Nuwave Investment Mgmt Ltd Liability stated it has 2,726 shares. Fragasso has 11,486 shares for 0.32% of their portfolio. Mercer Advisers Inc holds 200 shares or 0.01% of its portfolio. Brown Brothers Harriman has invested 0.69% in Dollar General Corporation (NYSE:DG). Umb Bancshares N A Mo holds 0.01% of its portfolio in Dollar General Corporation (NYSE:DG) for 2,657 shares. Highland Ltd, a Tennessee-based fund reported 19,485 shares. Adams Diversified Equity Fund Inc holds 193,937 shares or 1.05% of its portfolio.

Professional Advisory Services Inc, which manages about $507.12 million US Long portfolio, upped its stake in State Street Corp (NYSE:STT) by 24,407 shares to 161,353 shares, valued at $13.52M in 2018Q3, according to the filing. It also increased its holding in Omnicom Group (NYSE:OMC) by 13,037 shares in the quarter, for a total of 199,526 shares, and has risen its stake in Facebook Inc (NASDAQ:FB).

Since September 7, 2018, it had 0 insider purchases, and 2 selling transactions for $6.13 million activity.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart